Dr. Benz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1825 4th St
San Francisco, CA 94143- Is this information wrong?
Education & Training
University of Michigan Medical SchoolClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2024
WA State Medical License 1973 - 2024
CT State Medical License 1981 - 2001- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 1991
Publications & Presentations
PubMed
- Assessment of salivary cadmium levels and breast density in the Marin Women's Study.George, M., Paff, S., Rojo, J., Powell, M., Pope, K., Shepard, J., Willis, M., Ereman, R., Prebil, L., Benz, C., Kerlikowske, K.> ;Cancer Medicine. 2024 Jan 1
- A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia.Mark Powell, Sophia Fuller, Erica Gunderson, Christopher Benz> ;Breast Cancer Research and Treatment. 2023 Jan 1
- 5 citationsTwenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.Annelie Johansson, Huma Dar, Laura J van 't Veer, Nicholas P Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau...> ;Journal of Clinical Oncology. 2022 Dec 10
- Join now to see all
Press Mentions
Gynecologic Disorders Suggests New Screening Options for Cardiovascular Disease, CancerMay 18th, 2022- Common Gene Variant in Three Seemingly Unrelated Gynecologic Disorders Suggests New Options for Screening for CVD and CancersMay 10th, 2022
Largest Cancer Genomics Study Spurs Efforts to Promote Specialized Clinical TrialsApril 7th, 2018- Join now to see all
Grant Support
- Mass Spectrometry To Decode PTM Patterns And Enhance The Biomarker Utility Of ERNational Cancer Institute2010–2012
- Polyribosome Targets Mediating MRNA Decay For Cancer Prediction And TherapyNational Cancer Institute2011
- Ucsc-Buck Inst. Genome Data Analysis Center For TCGA Research Network (GDAC)National Cancer Institute2009–2011
- Clinical Significance Of Functionally Defective Estrogen ReceptorNational Center For Research Resources2006–2008
- Defective Estrogen Receptors In Breast TumorsNational Cancer Institute2000–2008
- Biology Of Breast Cancers Arising In Older WomenNational Institute On Aging2003–2007
- Therapeutic Modulation Of Breast Cancer OncogenesNational Cancer Institute2000–2007
- Ecological &Clin Sig Of Defective Estrogen Receptor From Human Breast TumorNational Center For Research Resources2005
- Ecological &Clin Sig Of Defective Estrogen ReceptorNational Center For Research Resources2004
- Developmental Research Program--Breast CancerNational Cancer Institute1995–2002
- Development Of Membrane Receptor Targeted And Tumoricidal Breast Cancer TherapyNational Cancer Institute1995–2002
- Defective Estrogen Receptors In Breast TumorsNational Cancer Institute1999–2000
- Activation Of Oncogenes And Receptors In Human Breast Cancer--Ets And Her2/NeuNational Cancer Institute1996–2000
- Therapeutic Modulation Of Breast Cancer OncogenesNational Cancer Institute1995–2000
- Antierbb2 Antibody Induced Protein InteractionsFogarty International Center1999
- Defective Estrogen Receptors In Human Breast TumorsNational Cancer Institute1996–1998
- Activation Of Oncogenes And Receptors In Human Breast Cancer--Ets And Her2/NeuNational Cancer Institute1995–1998
- Therapeutic Modulation Breast Cancer Oncogenes, EstrogenNational Cancer Institute1994
- Activation Of Oncogenes And Receptors In Breast CancerNational Cancer Institute1991–1994
- Therapeutic Modulation Of Breast Cancer Oncogenes &EstrNational Cancer Institute1991–1993
- Modulation Of Receptor Signal Trandsuction.....National Cancer Institute1992
- Activation Of Oncogenes And Receptors In Breast CancerNational Cancer Institute1990
- Investigations Into Selectivity And Monitoring SystemsNational Cancer Institute1988–1990
- Antiestrogen/5-Fu Drug Combinations In Breast CancerNational Cancer Institute1987–1990
- Transforming Genes Expression In Breast CancerNational Cancer Institute1989
- Steroids And Antimetabolites In Pancreatic CarcinomaNational Cancer Institute1985–1986
- 5-Fluorouracil And Antiestrogens In Breast CancerNational Cancer Institute1985–1986
Hospital Affiliations
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
UCSF Medical CenterSan Francisco, California
Chinese HospitalSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
